Abstract

The interaction of copper (II), zinc(II) and cadmium(II) with Trimethoprim (2,4-diamino-5-(3′,4′,5′-trimethoxybenzyl) pyrimidine) has been studied. The crystal structures of [Zn(Trim) 2Cl 2] ( 2) and [Cd(Trim)Cl 2(CH 3OH)] n ( 4) are reported. Compound ( 2) exhibits a distorted tetrahedral environment around the metal center and crystallizes in the triclinic space group P1̄ with a=10.2397(6), b=10.4500(6), c=16.3336(16) Å, α=96.141(8), β=106.085(5), γ=96.551(5)° and Z=2. In complex ( 4), the Cd(II) centers are bridged sequentially by two chlorine ions to form infinite chains and present a six-coordinated environment; the compound crystallizes in the monoclinic P2 1/ C space group with a=13.958(5), b=7.532(2), c=18.390(2) Å, α=90, β=97.32(5), γ=90° and Z=4. In both structures the Trimethoprim acts as a monodentate ligand through the pyrimidinic nitrogen N(1) atom. The characterization of the Cu(Trim) 2(CH 3O)(ClO 4) complex through EPR and magnetic measurements suggests a binuclear or polinuclear nature, with bridging methoxo groups. The complexes were screened for their activity against several bacteria, showing activity similar to that of trimethoprim.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.